Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-035034

Director acquired 7,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Molineaux Christopher P. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2020-06-06 Exercise or conversion : show line 1 in the form +7,333 23,891 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-06-04 Grant or award : show line 2 in the form Option Grant (right to buy) +16,500 16,500 D
2020-06-06 Exercise or conversion : show line 3 in the form Restricted Stock Units −7,333 0 D
Loading xslF345X03/doc4.xml…